Evidence map›Paper›PMID 24305557›Full record

ArticleAging cell2014

A novel approach to rapidly prevent age-related cognitive decline.

Paul A Adlard, Amelia Sedjahtera, Lydia Gunawan, Lisa Bray, Dominic Hare, Jessica Lear, Philip Doble, Ashley I Bush, David I Finkelstein, Robert A Cherny

Open access · hybridAbstract read
In one paragraph

Article in Aging cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 50 citations in OpenAlex.

  1. The Astrocytic Zinc Transporter ZIP12 Is a Synaptic Protein That Contributes to Synaptic Zinc Levels in the Mouse Auditory Cortex.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Iron in Neurodegeneration - Cause or Consequence?Frontiers in neuroscience · 2019
    Review
  14. Weakened Intracellular ZnMolecular neurobiology · 2018
    Article
  15. Characteristic of Extracellular ZnMolecular neurobiology · 2018
    Article
  16. Article
  17. The Impact of Synaptic ZnInternational journal of molecular sciences · 2017
    Review
  18. Review
  19. Article
  20. Cross-Sectional and Longitudinal Effects ofFrontiers in aging neuroscience · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Paul A AdlardThe Florey Institute of Neuroscience and Mental Health, Kenneth Myer Building, At Genetics Lane on Royal Parade, The University of Melbourne, Melbourne, Vic., 3010, Australia.
Amelia Sedjahtera
Lydia Gunawan
Lisa Bray
Dominic Hare
Jessica Lear
Philip Doble
Ashley I Bush
David I Finkelstein
Robert A Cherny
Florey Institute of Neuroscience and Mental Health · AUUniversity of Melbourne · AUUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The loss of cognitive function is a pervasive and often debilitating feature of the aging process for which there are no effective therapeutics. We hypothesized that a novel metal chaperone (PBT2; Prana Biotechnology, Parkville, Victoria, Australia) would enhance cognition in aged rodents. We show here that PBT2 rapidly improves the performance of aged C57Bl/6 mice in the Morris water maze, concomitant with increases in dendritic spine density, hippocampal neuron number and markers of neurogenesis. There were also increased levels of specific glutamate receptors (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and N-methyl-D-aspartate), the glutamate transporter (VGLUT1) and glutamate itself. Markers of synaptic plasticity [calmodulin-dependent protein kinase II (CaMKII) and phosphorylated CaMKII, CREB, synaptophysin] were also increased following PBT2 treatment. We also demonstrate that PBT2 treatment results in a subregion-specific increase in hippocampal zinc, which is increasingly recognized as a potent neuromodulator. These data demonstrate that metal chaperones are a novel approach to the treatment of age-related cognitive decline.

Indexed as

AgingAnimalsBehavior, AnimalBiomarkersCell CountClioquinolCognition DisordersDendritic SpinesFemaleGlutamic AcidHippocampusMaze LearningMiceMice, Inbred C57BLNeurogenesisNeuronal PlasticityBiomarkersClioquinolGlutamic AcidPBT2 compoundProtein Phosphatase 2Receptors, GlutamateSlc17a7 protein, mouseVesicular Glutamate Transport Protein 1Zincaginganti-agingcognitionPBT2zinc

Identifiers

PMID24305557
PMCPMC4331782
OpenAlexW1968763345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.